|
1
|
Sonneveld P, Avet-Loiseau H, Lonial S,
Usmani S, Siegel D, Anderson KC, Chng WJ, Moreau P, Attal M, Kyle
RA, et al: Treatment of multiple myeloma with high-risk
cytogenetics: A consensus of the International myeloma working
group. Blood. 127:2955–2962. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdi J, Chen G and Chang H: Erratum: Drug
resistance in multiple myeloma: Latest findings and new concepts on
molecular mechanisms. Oncotarget. 6:73642015.PubMed/NCBI
|
|
3
|
Mimura N, Hideshima T and Anderson KC:
Novel therapeutic strategies for multiple myeloma. Exp Hematol.
43:732–741. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liao TL, Chen YM, Hsieh CW, Chen HH, Lee
HC, Hung WT, Tang KT and Chen DY: Upregulation of circulating
microRNA-134 in adult-onset Still's disease and its use as
potential biomarker. Sci Rep. 7:42142017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pilli T, Cantara S, Marzocchi C, Cardinale
S, Santini C, Cevenini G and Pacini F: Diagnostic value of
circulating microRNA-95 and −190 in the differential diagnosis of
thyroid nodules: A validation study in 1000 consecutive patients.
Thyroid. 27:1053–1057. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng P, Guo H, Li G, Han S, Luo F and Liu
Y: PSMB4 promotes multiple myeloma cell growth by activating
NF-κB-miR-21 signaling. Biochem Biophys Res Commun. 458:328–333.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen X, Guo Y, Yu J, Qi J, Shi W, Wu X, Ni
H and Ju S: miRNA-202 in bone marrow stromal cells affects the
growth and adhesion of multiple myeloma cells by regulating B
cell-activating factor. Clin Exp Med. 16:307–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu
M, Tepper CG, Evans CP, Kung HJ and deVere White RW: An
androgen-regulated miRNA suppresses Bak1 expression and induces
androgen-independent growth of prostate cancer cells. Proc Natl
Acad Sci USA. 104:19983–19988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bousquet M, Quelen C, Rosati R, Mansat-De
Mas V, La Starza R, Bastard C, Lippert E, Talmant P,
Lafage-Pochitaloff M, Leroux D, et al: Myeloid cell differentiation
arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid
leukemia with the t(2;11) (p21;q23) translocation. J Exp Med.
205:2499–2506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anderson KC: Progress and paradigms in
multiple myeloma. Clin Cancer Res. 22:5419–5427. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riazalhosseini B, Mohamed R, Apalasamy YD,
Langmia IM and Mohamed Z: Circulating microRNA as a marker for
predicting liver disease progression in patients with chronic
hepatitis B. Rev Soc Bras Med Trop. 50:161–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu L, Hu B, Zhao B, Liu Y, Yang Y, Zhang L
and Chen J: Circulating microRNA-422a is associated with lymphatic
metastasis in lung cancer. Oncotarget. 8:42173–42188.
2017.PubMed/NCBI
|
|
15
|
Xu G, Zhang Z, Zhang L, Chen Y, Li N, Lv
Y, Li Y and Xu X: miR-4326 promotes lung cancer cell proliferation
through targeting tumor suppressor APC2. Mol Cell Biochem.
443:151–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bertero T, Gastaldi C, Bourget-Ponzio I,
Imbert V, Loubat A, Selva E, Busca R, Mari B, Hofman P, Barbry P,
et al: miR-483-3p controls proliferation in wounded epithelial
cells. FASEB J. 25:3092–3105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morelli E, Leone E, Cantafio ME, Di
Martino MT, Amodio N, Biamonte L, Gullà A, Foresta U, Pitari MR,
Botta C, et al: Selective targeting of IRF4 by synthetic
microRNA-125b-5p mimics induces anti-multiple myeloma activity in
vitro and in vivo. Leukemia. 29:2173–2183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu H, Yang T, Fu S, Chen X, Guo L and Ni
Y: MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells
by targeting CCND1. Biochem Biophys Res Commun. 444:104–108. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng K, Zhou X, Yu J, Li Q, Wang H, Li M,
Shao Z, Zhang F, Luo Y, Shen Z, et al: Epigenetic silencing of
miR-490-3p promotes development of an aggressive colorectal cancer
phenotype through activation of the Wnt/β-catenin signaling
pathway. Cancer Lett. 376:178–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou B, Wang Y, Jiang J, Jiang H, Song J,
Han T, Shi J and Qiao H: The long noncoding RNA colon
cancer-associated transcript-1/miR-490 axis regulates gastric
cancer cell migration by targeting hnRNPA1. IUBMB Life. 68:201–210.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang W, Zhang C, Chen H, Li L, Tu Y, Liu
C, Shi S, Zen K and Liu Z: Evaluation of microRNAs miR-196a,
miR-30a-5P, and miR-490 as biomarkers of disease activity among
patients with FSGS. Clin J Am Soc Nephrol. 9:1545–1552. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma Q, Chen Z, Jia G, Lu X, Xie X and Jin
W: The histone demethylase PHF8 promotes prostate cancer cell
growth by activating the oncomiR miR-125b. Onco Targets Ther.
8:1979–1988. 2015.PubMed/NCBI
|
|
24
|
Liu J, Guo B, Chen Z, Wang N, Iacovino M,
Cheng J, Roden C, Pan W, Khan S, Chen S, et al: miR-125b promotes
MLL-AF9-driven murine acute myeloid leukemia involving a
VEGFA-mediated non-cell-intrinsic mechanism. Blood. 129:1491–1502.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Visone R, Pallante P, Vecchione A,
Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V,
Borbone E, et al: Specific microRNAs are downregulated in human
thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Veerla S, Lindgren D, Kvist A, Frigyesi A,
Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, et
al: MiRNA expression in urothelial carcinomas: important roles of
miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and
metastasis, and frequent homozygous losses of miR-31. Int J Cancer.
124:2236–2242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin
XH and Ma X: MiR-125b expression affects the proliferation and
apoptosis of human glioma cells by targeting Bmf. Cell Physiol
Biochem. 23:347–358. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B,
Korzh V, Lodish HF and Lim B: MicroRNA-125b is a novel negative
regulator of p53. Genes Dev. 23:862–876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Murray MY, Rushworth SA, Zaitseva L,
Bowles KM and Macewan DJ: Attenuation of dexamethasone-induced cell
death in multiple myeloma is mediated by miR-125b expression. Cell
Cycle. 12:2144–2153. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen H and Xu Z:
Hypermethylation-associated silencing of miR-125a and miR-125b: A
potential marker in colorectal cancer. Dis Markers.
2015:3450802015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Tan G, Dong L, Cheng L, Li K, Wang
Z and Luo H: Circulating MiR-125b as a marker predicting
chemoresistance in breast cancer. PLoS One. 7:e342102012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao
B, Dai Z, Cao Y, Fan J and Zhou J: Serum exosomal miR-125b is a
novel prognostic marker for hepatocellular carcinoma. Onco Targets
Ther. 10:3843–3851. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong KY, Li Z, Zhang X, Leung GK, Chan GC
and Chim CS: Epigenetic silencing of a long non-coding RNA KIAA0495
in multiple myeloma. Mol Cancer. 14:1752015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jairajpuri DS, Malalla ZH, Mahmood N and
Almawi WY: Circulating microRNA expression as predictor of
preeclampsia and its severity. Gene. 627:543–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Niu J, Xue A, Chi Y, Xue J, Wang W, Zhao
Z, Fan M, Yang CH, Shao ZM, Pfeffer LM, et al: Induction of
miRNA-181a by genotoxic treatments promotes chemotherapeutic
resistance and metastasis in breast cancer. Oncogene. 35:1302–1313.
2016. View Article : Google Scholar : PubMed/NCBI
|
